T1	Lab_value_phrase 1687 1711	A20) by RT-PCR (Fig.2C).
T2	Lab_value 1707 1709	2C
T3	Diagnostic_procedure 1687 1690	A20
T4	Lab_value_phrase 1712 1846	The patient then received crizotinib (250 mg twice daily) as third-line therapy in May 2013 with an impressive symptomatic improvement
T5	Lab_value 1750 1756	250 mg
T6	Diagnostic_procedure 1738 1748	crizotinib
